Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.4254/wjh.v7.i13.1755 http://scihub22266oqcxt.onion/10.4254/wjh.v7.i13.1755 C4491904!4491904!26167248     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       World+J+Hepatol 2015 ; 7 (13): 1755-60 Nephropedia Template TP {{tp|p=26167248|t=2015. Surgical treatment of intra hepatic recurrence of hepatocellular carcinoma |pdf=|usr=}}{{26167248}} gab.com Text Surgical treatment of intra hepatic recurrence of hepatocellular carcinoma JO: World J Hepatol http://www.kidney.de/pget.php?&tw=1&pmid=26167248 #FOAvip Recurrence after hepatocellular carcinoma (HCC) is frequent. Currently, there are no recommendations on therapeutic strategy after recurrence of HCC. Whereas the 5 year-recurrence rate after resection of HCC is 100%, this drops to 15% after primary liver transplantation. Repeat hepatectomy and salvage liver transplantation (SLT) could be performed in selected patients to treat recurrent HCC and enable prolonged overall survival after treatment of recurrence. Other therapies such as local ablation, chemoembolization or sorafenib could be proposed to those patients unable to benefit from resection or SLT. A clear definition of the place of SLT and ?prophylactic? liver transplantation is required. Indeed, identifying risks factors for recurrence at time of primary liver resection of HCC may help to avoid recurrence beyond Milan criteria and non-resectable situations. In this review, we summarize the recent data available in the literature on the feasibility and outcomes of repeat hepatectomy and SLT as treatment for recurrent HCC. Twit Text FOAVip Surgical treatment of intra hepatic recurrence of hepatocellular carcinoma ????World J Hepatol http://www.kidney.de/pget.php?&tw=1&pmid=26167248 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26167248 #FOAvip English Wikipedia <ref>{{Cite pmid|26167248}}</ref> Surgical treatment of intra hepatic recurrence of hepatocellular carcinoma #MMPMID26167248 Lacaze L; Scotté M World J Hepatol 2015[Jul]; 7 (13): 1755-60 PMID26167248show ga Recurrence after hepatocellular carcinoma (HCC) is frequent. Currently, there are no recommendations on therapeutic strategy after recurrence of HCC. Whereas the 5 year-recurrence rate after resection of HCC is 100%, this drops to 15% after primary liver transplantation. Repeat hepatectomy and salvage liver transplantation (SLT) could be performed in selected patients to treat recurrent HCC and enable prolonged overall survival after treatment of recurrence. Other therapies such as local ablation, chemoembolization or sorafenib could be proposed to those patients unable to benefit from resection or SLT. A clear definition of the place of SLT and ?prophylactic? liver transplantation is required. Indeed, identifying risks factors for recurrence at time of primary liver resection of HCC may help to avoid recurrence beyond Milan criteria and non-resectable situations. In this review, we summarize the recent data available in the literature on the feasibility and outcomes of repeat hepatectomy and SLT as treatment for recurrent HCC. äSurgical treatment of intra hepatic recurrence of hepatocellular carci(epmc).pdf DeepDyve Pubget Overpricing